Filing Flows › QHSLab (USAQ) › Q1 2026 › vs Q1 2025
QHSLab (USAQ) Q1 2026 vs Q1 2025 (year over year)
QHSLab's revenue rose $83K (+13%) from $645K in Q1 2025 to $729K in Q1 2026. The biggest changes: Integrated Service Program +$212K (+130%); Allergy Diagnostic Kit Sales −$36K (-14%); Immunotherapy Treatment Sales −$6K (-6%).
QHSLab, Q1 2026: revenue $729K (+13% year over year), operating margin -13.0%, net loss $104K, operating cash flow −$200K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Integrated Service Program | $375K | $163K | $212K | +130% |
| Allergy Diagnostic Kit Sales | $229K | $265K | −$36K | -14% |
| Immunotherapy Treatment Sales | $91K | $97K | −$6K | -6% |
| Subscription Revenue | $12K | $9K | $3K | +29% |
| Shipping and Handling | $12K | $10K | $2K | +17% |
| Training and Other Revenue | $11K | $12K | −$2K | -13% |
| Revenue | $729K | $645K | $83K | +13% |
| Net loss | $104K | $80K | $24K | +31% |
| Costs & expenses | $833K | $725K | $108K | +15% |
| Operating costs | $823K | $657K | $166K | +25% |
| Interest & other, net | $10K | $68K | −$58K | -86% |
| Cost of revenue | $258K | $215K | $42K | +20% |
| Research & development | $121K | $124K | −$3K | -3% |
| Sales & marketing | $218K | $144K | $74K | +51% |
| General & admin | $208K | $156K | $52K | +34% |
| Other operating costs | $18K | $18K | $0 | 0% |
| Operating cash sources | $218K | $86K | $132K | +153% |
| Depreciation & amortization | $18K | $37K | −$19K | -51% |
| Cash used in operations | $200K | $50K | $151K | +304% |
| Net loss absorbed | $104K | $80K | $24K | +31% |
| Working capital & other | $114K | $7K | $108K | 17× |
Questions
How much did QHSLab's revenue grow year over year in Q1 2026?
QHSLab's revenue rose $83K (+13%) from $645K in Q1 2025 to $729K in Q1 2026.
What drove QHSLab's revenue change in Q1 2026?
Integrated Service Program +$212K (+130%); Allergy Diagnostic Kit Sales −$36K (-14%); Immunotherapy Treatment Sales −$6K (-6%).